Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Roadmap on digital holography [Invited]

  • Javidi, Bahram
  • Carnicer González, Arturo
  • Anand, Arun
  • Barbastathis, George
  • Chen, Wen
  • Ferraro, Pietro
  • Goodman, J.W.
  • Horisaki, Ryoichi
  • Khare, Kedar
  • Kujawinska, Malgorzata
  • Leitgeb, Rainer A.
  • Marquet, Pierre
  • Nomura, Takanori
  • Ozcan, Aydogan
  • Park, YongKeun
  • Pedrini, Giancarlo
  • Picart, Pascal
  • Rosen, Joseph
  • Saavedra, Genaro
  • Shaked, Natan T.
  • Stern, Adrian
  • Tajahuerce Romera, Enrique
  • Tian, Lei
  • Wetzstein, Gordon
  • Yamaguchi, Masahiro
This Roadmap article on digital holography provides an overview of a vast array of research activities in the field of digital holography. The paper consists of a series of 25 sections from the prominent experts in digital holography presenting various aspects of the field on sensing, 3D imaging and displays, virtual and augmented reality, microscopy, cell identification, tomography, label-free live cell imaging, and other applications. Each section represents the vision of its author to describe the significant progress, potential impact, important developments, and challenging issues in the field of digital holography.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity

  • Tedbury, Philip R.
  • Manfredi, Candela
  • Degenhardt, Frauke
  • Conway, Joseph
  • Horwath, Michael C.
  • McCracken, Courtney
  • Sorscher, Adam J.
  • Moreau, Sandy
  • Wright, Christine
  • Edwards, Carolina
  • Brewer, Jo
  • Guarner, Jeannette
  • Wit, Emmie de
  • Williamson, Brandi N.
  • Suthar, Mehul S.
  • Ong, Yee T.
  • Roback, John D.
  • Alter, David N.
  • Holter, Jan Cato
  • Karlsen, Tom H.
  • Sacchi, Nicoletta
  • Romero-Gómez, Manuel
  • Invernizzi, Pietro
  • Fernández, Javier
  • Buti, María
  • Albillos, Agustín
  • Julià, Antonio
  • Valenti, Luca
  • Asselta, Rosanna
  • Banales, Jesús M.
  • Bujanda, Luis
  • Cid, Rafael de
  • Franke, André
  • Severe COVID-19 GWAS group
  • Horra, Carmen de la
  • Maya-Miles, Douglas
  • Calderón, Enrique J.
  • Medrano, Francisco Javier
  • Ampuero, Javier
  • Martín, Javier
  • Dopazo, Joaquín
  • Delgado, Juan
  • Guerrero, Juan M.
  • Acosta-Herrera, Marialbert
  • Gallego-Durán, Rocío
  • Morilla Romero de la Osa, R.
  • Friaza Patiño, Vicente
  • Sarafianos, Stefan G.
  • Hong, Jeong S.
  • Sorscher, Eric J.
  • Ehrhardt, Annette
Patients with cystic fibrosis (CF) exhibit pronounced respiratory damage and were initially considered among those at highest risk for serious harm from SARS-CoV-2 infection. Numerous clinical studies have subsequently reported that individuals with CF in North America and Europe—while susceptible to severe COVID-19—are often spared from the highest levels of virus-associated mortality. To understand features that might influence COVID-19 among patients with cystic fibrosis, we studied relationships between SARS-CoV-2 and the gene responsible for CF (i.e., the cystic fibrosis transmembrane conductance regulator, CFTR). In contrast to previous reports, we found no association between CFTR carrier status (mutation heterozygosity) and more severe COVID-19 clinical outcomes. We did observe an unexpected trend toward higher mortality among control individuals compared with silent carriers of the common F508del CFTR variant—a finding that will require further study. We next performed experiments to test the influence of homozygous CFTR deficiency on viral propagation and showed that SARS-CoV-2 production in primary airway cells was not altered by the absence of functional CFTR using two independent protocols. On the contrary, experiments performed in vitro strongly indicated that virus proliferation depended on features of the mucosal fluid layer known to be disrupted by absent CFTR in patients with CF, including both low pH and increased viscosity. These results point to the acidic, viscous, and mucus-obstructed airways in patients with cystic fibrosis as unfavorable for the establishment of coronaviral infection. Our findings provide new and important information concerning relationships between the CF clinical phenotype and severity of COVID-19., This work was supported by the Italian Ministry of Health (Ministero della Salute) [Ricerca Finalizzata RF-2016-02364358]; Fondazione IRCCS Ca′ Granda Ospedale Maggiore Policlinico, Ricerca corrente; Fondazione IRCCS Ca′ Granda core COVID-19 Biobank [RC100017A]; “Liver BIBLE” [PR-0391]; and Innovative Medicines Initiative 2 joint undertaking of the European Union (EU) Horizon 2020 research and innovation programme and European Federation of Pharmaceutical Industries and Associations Programme Horizon 2020 [under grant agreement No. 777377] for the project LITMUS and the European Union, programme “Photonics” [under grant agreement 101016726] to LV. JCH was funded by the Research Council of Norway [grant no 312780] and a philanthropic donation from Vivaldi Invest A/S owned by Jon Stephenson von Tetzchner. The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report. AF was supported by a grant from the German Federal Ministry of Education and Research [01KI20197]. This work was also funded by a generous philanthropic donation from Banca Intesa San Paolo to RA. This study makes use of data generated by the GCATI Genomes for Life. Cohort study of the Genomes of Catalonia from Institut Germans Trias I Pujol (IGTP); IGTP is part of the CERCA Program/Generalitat de Catalunya. GCAT is supported by Acción de Dinamización del ISCIII-MINECO and the Ministry of Health of the Generalitat of Catalunya [ADE 10/00026], with additional support by the Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) [2017-SGR 529], National Grant [PI18/01512], and VEIS project [001-P-001647], co-funded by European Regional Development Fund (ERDF), “A way to build Europe.” EdW and BNW were supported by the Intramural Research Program, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). PRT and SGS received funding from NIH NIAID [R01 AI167356]., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Roadmap on digital holography [Invited]

  • Javidi, Bahram
  • Carnicer González, Arturo
  • Anand, Arun
  • Barbastathis, George
  • Chen, Wen
  • Ferraro, Pietro
  • Goodman, J.W.
  • Horisaki, Ryoichi
  • Khare, Kedar
  • Kujawinska, Malgorzata
  • Leitgeb, Rainer A.
  • Marquet, Pierre
  • Nomura, Takanori
  • Ozcan, Aydogan
  • Park, YongKeun
  • Pedrini, Giancarlo
  • Picart, Pascal
  • Rosen, Joseph
  • Saavedra, Genaro
  • Shaked, Natan T.
  • Stern, Adrian
  • Tajahuerce Romera, Enrique
  • Tian, Lei
  • Wetzstein, Gordon
  • Yamaguchi, Masahiro
This Roadmap article on digital holography provides an overview of a vast array of research activities in the field of digital holography. The paper consists of a series of 25 sections from the prominent experts in digital holography presenting various aspects of the field on sensing, 3D imaging and displays, virtual and augmented reality, microscopy, cell identification, tomography, label-free live cell imaging, and other applications. Each section represents the vision of its author to describe the significant progress, potential impact, important developments, and challenging issues in the field of digital holography.